Mr. Speaker, I thank my hon. colleague for his question.
It is true that when we were studying Bill C-6, some witnesses appeared before us to discuss that particular aspect. During the health committee's work last spring, we spent only one meeting examining the whole issue of nanotechnology, its growing use and the repercussions this new technology can have on human health. This is definitely something that needs to be examined further in committee. I did not get the impression that any parliamentarians, from any of the parties, were against the idea of examining these matters further.
Of course, when we were studying Bill C-6, some people expressed certain concerns that were not addressed in the bill, but at that stage, it was important to update the 40-year-old legislation. So this bill updates the legislation. The committee and this Parliament will have every opportunity, I have no doubt, to make other improvements through other means. For instance, the member mentioned counterfeit products. There is also the question of labelling, in order to ensure that when consumers purchase a product, they know exactly what is in it. I think all parliamentarians agree on that issue.